ArticleClinical and molecular hepatology2012

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.

Byung Chul You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.